Skip to main content

Table 4 Multivariate predictors of CD4 change at 12 months in HIV-infected individuals at Jimma University Specialized Hospital, January 2006 to December 2011

From: Nutritional status and its effect on treatment outcome among HIV infected clients receiving HAART in Ethiopia: a cohort study

Variables Numbers B [95 % CI] p value
Age 340 −1.91 [−3.238, −0.582] 0.005
Sex
 Female 200 Reference  
 Male 140 −38.67 [−81.973, 4.633] 0.080
BMI
 <18.5 170 −21.54 [−64.197, 21.109] 0.321
 ≥18.5 170 Reference  
HAART regimen
 Stavudine based 219 25.57 [−34.277, 85.420] 0.401
 Zidovudine based 72 −17.53 [−87.25, 52.190] 0.621
 Tenofovir based 49 Reference  
Baseline CD4
 <100 5 188.75 [−9.859, 387.359] 0.062
 100–199 94 201.29 [2.916, 399.661] 0.047
 200–350 139 133.33 [−64.785, 81.773] 0.186
 >350 102 Reference  
WHO stage
 Stage 1 65 Reference  
 Stage 2 95 −15.96 [−78.139, 46.212] 0.614
 Stage 3 144 24.17 [−33.426, 81.773] 0.179
 Stage 4 36 −63.89 [−157.331, 29.548] 0.409
Educational status
 Not educated 69 Reference  
 Primary 122 52.75 [−4.906, 110.408] 0.073
 Secondary 106 40.11 [−18.174, 98.400] 0.177
 Tertiary 42 40.113 [−76.277, 83.098] 0.933